Pelaris, Lorrie-mae B.
HRN: 20-75-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2022
AMPICILLIN 1GM (VIAL)
07/19/2022
07/26/2022
IV
2gms
Q6H
G1P0 40 Weeks AOG; PROM X 4 Hours
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes